Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patientsMarch 31, 2014Lipid DisordersObesity
'Revolutionary' LDL lowering shown in evolocumab phase III trialsMarch 30, 2014Lipid DisordersObesity
Evidence needed on obesity definition, treatment, AACE declaresMarch 26, 2014Lipid DisordersObesityPediatricsBusiness of Medicine
Choice vs. regulation: the role of public policy in obesity managementMarch 25, 2014ObesityBusiness of Medicine
The future of obesity treatments could include endoscopically placed devicesFebruary 24, 2014DiabetesObesity
Obesity at age 20 associated with increased risk of multiple sclerosisFebruary 11, 2014PediatricsObesity
